Abstract
Abstract Introduction Periprosthetic joint infection has remained the most annihilating adversity and intriguing challenge confronting orthopaedic surgeons following joint arthroplasty procedures globally. The criticality of a surgeon’s decision in identifying an underlying infection prior to revision arthroplasties and in managing such situations appropriately can never be understated. The current article reviews the role of novel synovial fluid biomarkers, including Polymerase Chain Reaction, C-Reactive Protein, leukocyte enzymes and other multiple molecular markers in identifying early PJIs. Conclusion The current literature is extremely scarce on these newer modalities, and their role in standard clinical practice is still greatly dubious and debatable. The research in this subject has a long way ahead and is reckoned in future, to elucidate our perspective and outlook on such scenarios.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
